Novavax
NVAX
#5525
Rank
โ‚น129.11 B
Marketcap
โ‚น792.40
Share price
-0.47%
Change (1 day)
48.29%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚น31.39 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚น1.02 Billion. In 2024 the company made an earning of -โ‚น14.68 Billion, an increase over its 2023 earnings that were of -โ‚น49.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น31.39 B-313.84%
2024 -โ‚น14.68 Billion-70.39%
2023 -โ‚น49.58 Billion-16.59%
2022 -โ‚น59.44 Billion-62.58%
2021 -โ‚น158.84 Billion320.54%
2020 -โ‚น37.77 Billion234.22%
2019 -โ‚น11.31 Billion-30.17%
2018 -โ‚น16.19 Billion1.69%
2017 -โ‚น15.92 Billion-36.44%
2016 -โ‚น25.04 Billion70.4%
2015 -โ‚น14.7 Billion89.27%
2014 -โ‚น7.77 Billion59.83%
2013 -โ‚น4.86 Billion81.9%
2012 -โ‚น2.68 Billion50.33%
2011 -โ‚น1.78 Billion
2009 -โ‚น3.51 Billion8.8%
2008 -โ‚น3.23 Billion18.01%
2007 -โ‚น2.74 Billion18.33%
2006 -โ‚น2.31 Billion168.31%
2005 -โ‚น0.87 Billion-62.51%
2004 -โ‚น2.3 Billion52.4%
2003 -โ‚น1.51 Billion-28.21%
2002 -โ‚น2.1 Billion
2000 -โ‚น1.2 Billion177%
1999 -โ‚น0.44 Billion-11.54%
1998 -โ‚น0.49 Billion10.64%
1997 -โ‚น0.45 Billion-9.62%
1996 -โ‚น0.49 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.533 T 4,260.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น955.75 B 2,617.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.322 T 3,662.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น927.97 B 2,538.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น23.65 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น26.95 Billion-176.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น1.93 B-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.77 Billion-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น25.07 B-28.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.50 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA